A technology transfer is often judged by whether the first batch passes. A better test is whether the receiving site can reproduce the process repeatedly, with the knowledge that made it work at the sending site.
Why transfers fail
ICH Q10 treats technology transfer as a lifecycle activity that should move product and process knowledge between development and manufacturing, and between sites. Transfers fail when the knowledge stays behind: unwritten operator know-how, equipment differences nobody compared, or an analytical method that works only in the originating laboratory.
What to transfer and document
- Process description with critical process parameters, critical quality attributes and the evidence linking them.
- Equipment comparison, including scale, mixing, drying, filling or compression characteristics, and a gap assessment.
- Analytical methods, with a transfer protocol showing the receiving laboratory can meet the original performance.
- Raw material and packaging specifications and approved suppliers.
- Cleaning, hold times and stability commitments.
- Risk assessments under ICH Q9(R1), updated for the new site.
The regulatory side of a transfer
A new manufacturing site is usually a regulatory change as well as a technical one. For an authorised medicine, adding or replacing a site is handled through a variation, and the dossier must reflect the validated process and the proposed batch sizes. In practice, regulatory strategy should be planned alongside the technical plan, since inspection status, a valid manufacturing authorisation covering the dosage form and the timing of GMP compliance evidence can all affect timelines. The receiving site needs process validation under Annex 15, and the technical agreement or quality agreement should define who owns each part of the work, in line with Chapter 7.
A practical sequence
A workable approach is to define the transfer plan and acceptance criteria early, run engineering or demonstration batches, evaluate the data against the criteria, then validate and submit. A formal report should close the transfer and record what was learned, including deviations. Change control should capture any later difference from the transferred process.
Governance and ownership
Name an accountable owner on each side, hold regular technical meetings and keep a single list of open actions. Small unresolved items, such as an unvalidated cleaning hold time or a method with no robustness data, tend to become supply problems after launch. Closing them before the first commercial batch is far cheaper than doing so afterwards.
How PQRA helps
PQRA can help structure a transfer plan that joins the technical, quality and regulatory strands, review quality agreements and gap assessments, and plan the variation strategy so that supply is not interrupted by avoidable timing problems.
Contact PQRA to discuss your next site transfer or contract manufacturer change.


No responses yet